These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30910650)

  • 1. Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication.
    Miller SM; Sumpio BJ; Miller MS; Erben Y; Cordova AC; Sumpio BE
    Ann Vasc Surg; 2019 Jul; 58():54-62. PubMed ID: 30910650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mortality in octogenarians treated for lifestyle limiting claudication.
    Erben Y; Mena-Hurtado CI; Miller SM; Jean RA; Sumpio BJ; Velasquez CA; Mojibian H; Aruny J; Dardik A; Sumpio BE
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1331-1338. PubMed ID: 29405592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.
    Agarwal S; Sud K; Shishehbor MH
    J Am Coll Cardiol; 2016 Apr; 67(16):1901-13. PubMed ID: 27012780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease.
    Vouyouka AG; Egorova NN; Salloum A; Kleinman L; Marin M; Faries PL; Moscowitz A
    J Vasc Surg; 2010 Nov; 52(5):1196-202. PubMed ID: 20674247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
    Martinez RA; Shnayder M; Parreco J; Gaffney L; Eby M; Cortolillo N; Lopez M; Zeltzer J
    Ann Vasc Surg; 2018 Oct; 52():96-107. PubMed ID: 29777842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia.
    Ochoa Chaar CI; Gholitabar N; Goodney P; Dardik A; Abougergi MS
    Ann Vasc Surg; 2019 Nov; 61():25-32.e2. PubMed ID: 31376536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety.
    Egorova NN; Guillerme S; Gelijns A; Morrissey N; Dayal R; McKinsey JF; Nowygrod R
    J Vasc Surg; 2010 Apr; 51(4):878-85, 885.e1. PubMed ID: 20045618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
    Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss.
    Brahmandam A; Gholitabar N; Cardella J; Nassiri N; Dardik A; Georgi M; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Jan; 70():237-244. PubMed ID: 32659417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis.
    Velescu A; Clará A; Cladellas M; Peñafiel J; Mateos E; Ibañez S; Mellado M
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):543-9. PubMed ID: 26810343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
    Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M
    J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary comparison of aortofemoral bypass to alternative inflow procedures in the Veteran population.
    McPhee JT; Madenci A; Raffetto J; Martin M; Gupta N
    J Vasc Surg; 2016 Dec; 64(6):1660-1666. PubMed ID: 27462000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coexisting aneurysms on open revascularization for aortoiliac occlusive disease.
    Daniel VT; Gupta N; Raffetto JD; McPhee JT
    J Vasc Surg; 2016 Apr; 63(4):944-8. PubMed ID: 26843353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.
    Kim TI; Brahmandam A; Sarac TP; Orion KC
    Vasc Med; 2020 Dec; 25(6):527-533. PubMed ID: 33019909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization.
    Shannon AH; Mehaffey JH; Cullen JM; Hawkins RB; Roy R; Upchurch GR; Robinson WP
    J Vasc Surg; 2019 Apr; 69(4):1167-1172.e1. PubMed ID: 30598355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.